Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2702893rdf:typepubmed:Citationlld:pubmed
pubmed-article:2702893lifeskim:mentionsumls-concept:C2349001lld:lifeskim
pubmed-article:2702893lifeskim:mentionsumls-concept:C0011860lld:lifeskim
pubmed-article:2702893lifeskim:mentionsumls-concept:C0012155lld:lifeskim
pubmed-article:2702893lifeskim:mentionsumls-concept:C0681850lld:lifeskim
pubmed-article:2702893lifeskim:mentionsumls-concept:C1706203lld:lifeskim
pubmed-article:2702893lifeskim:mentionsumls-concept:C2697811lld:lifeskim
pubmed-article:2702893lifeskim:mentionsumls-concept:C0007004lld:lifeskim
pubmed-article:2702893lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2702893lifeskim:mentionsumls-concept:C0439855lld:lifeskim
pubmed-article:2702893lifeskim:mentionsumls-concept:C1550501lld:lifeskim
pubmed-article:2702893lifeskim:mentionsumls-concept:C0597423lld:lifeskim
pubmed-article:2702893pubmed:issue2lld:pubmed
pubmed-article:2702893pubmed:dateCreated1989-5-16lld:pubmed
pubmed-article:2702893pubmed:abstractTextThis study examined the safety of an isocaloric high-complex carbohydrate low-saturated fat diet (HICARB) in obese patients with non-insulin-dependent diabetes mellitus (NIDDM). Although hypocaloric diets should be recommended to these patients, many find compliance with this diet difficult; therefore, the safety of an isocaloric increase in dietary carbohydrate needs assessment. Lipoprotein cholesterol and triglyceride (TG, mg/dl) concentrations in isocaloric high-fat and HICARB diets were compared in 7 NIDDM subjects (fat 32 +/- 3%, fasting glucose 190 +/- 38 mg/dl) and 6 nondiabetic subjects (fat 33 +/- 5%). They ate a high-fat diet (43% carbohydrate; 42% fat, polyunsaturated to saturated 0.3; fiber 9 g/1000 kcal; cholesterol 550 mg/day) for 7-10 days. Control subjects (3 NIDDM, 3 nondiabetic) continued this diet for 5 wk. The 13 subjects changed to a HICARB diet (65% carbohydrate; 21% fat, polyunsaturated to saturated 1.2; fiber 18 g/1000 kcal; cholesterol 550 mg/day) for 5 wk. NIDDM subjects on the HICARB diet had decreased low-density lipoprotein cholesterol (LDL-chol) concentrations (107 vs. 82, P less than .001), but their high-density lipoprotein cholesterol (HDL-chol) concentrations, glucose, and body weight were unchanged. Changes in total plasma TG concentrations in NIDDM subjects were heterogeneous. Concentrations were either unchanged or had decreased in 5 and increased in 2 NIDDM subjects. Nondiabetic subjects on the HICARB diet had decreased LDL-chol (111 vs. 81, P less than .01) and unchanged HDL-chol and plasma TG concentrations).(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:2702893pubmed:languageenglld:pubmed
pubmed-article:2702893pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2702893pubmed:citationSubsetIMlld:pubmed
pubmed-article:2702893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2702893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2702893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2702893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2702893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2702893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2702893pubmed:statusMEDLINElld:pubmed
pubmed-article:2702893pubmed:monthFeblld:pubmed
pubmed-article:2702893pubmed:issn0149-5992lld:pubmed
pubmed-article:2702893pubmed:authorpubmed-author:HowardB VBVlld:pubmed
pubmed-article:2702893pubmed:authorpubmed-author:AbbottW GWGlld:pubmed
pubmed-article:2702893pubmed:authorpubmed-author:GrundyS MSMlld:pubmed
pubmed-article:2702893pubmed:authorpubmed-author:BoyceV LVLlld:pubmed
pubmed-article:2702893pubmed:issnTypePrintlld:pubmed
pubmed-article:2702893pubmed:volume12lld:pubmed
pubmed-article:2702893pubmed:ownerNLMlld:pubmed
pubmed-article:2702893pubmed:authorsCompleteYlld:pubmed
pubmed-article:2702893pubmed:pagination102-7lld:pubmed
pubmed-article:2702893pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2702893pubmed:meshHeadingpubmed-meshheading:2702893-...lld:pubmed
pubmed-article:2702893pubmed:meshHeadingpubmed-meshheading:2702893-...lld:pubmed
pubmed-article:2702893pubmed:meshHeadingpubmed-meshheading:2702893-...lld:pubmed
pubmed-article:2702893pubmed:meshHeadingpubmed-meshheading:2702893-...lld:pubmed
pubmed-article:2702893pubmed:meshHeadingpubmed-meshheading:2702893-...lld:pubmed
pubmed-article:2702893pubmed:meshHeadingpubmed-meshheading:2702893-...lld:pubmed
pubmed-article:2702893pubmed:meshHeadingpubmed-meshheading:2702893-...lld:pubmed
pubmed-article:2702893pubmed:meshHeadingpubmed-meshheading:2702893-...lld:pubmed
pubmed-article:2702893pubmed:meshHeadingpubmed-meshheading:2702893-...lld:pubmed
pubmed-article:2702893pubmed:meshHeadingpubmed-meshheading:2702893-...lld:pubmed
pubmed-article:2702893pubmed:meshHeadingpubmed-meshheading:2702893-...lld:pubmed
pubmed-article:2702893pubmed:meshHeadingpubmed-meshheading:2702893-...lld:pubmed
pubmed-article:2702893pubmed:meshHeadingpubmed-meshheading:2702893-...lld:pubmed
pubmed-article:2702893pubmed:year1989lld:pubmed
pubmed-article:2702893pubmed:articleTitleEffects of replacing saturated fat with complex carbohydrate in diets of subjects with NIDDM.lld:pubmed
pubmed-article:2702893pubmed:affiliationClinical Diabetes and Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, Arizona.lld:pubmed
pubmed-article:2702893pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2702893pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:2702893pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2702893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2702893lld:pubmed